New York giant Bausch + Lomb has announced a global licensing agreement to market KeraSoft® contact lenses – developed by UltraVision CLPL in Leighton Buzzard – throughout the world.
The financial terms of the deal remain confidential but with Bausch + Lomb now behind KeraSoft both companies expect the lenses will give sight back to literally millions of people around the world.
J Keith Lomas, group CEO of UltraVision CLPL, said: “We’re thrilled with this transformational deal. We’ve developed life-changing KeraSoft technology in the UK and Bausch + Lomb, a clear market leader, will now use its brand and channels to take it global.
“We will continue with our core focus on developing and licensing innovative technologies.”
Headquartered in Rochester, New York, Bausch + Lomb has more than 11,000 employees and products available in more than 100 countries. KeraSoft lenses, recognised with a Queen’s Award for Enterprise and Innovation, are a patented combination of the latest technologies in soft and silicone hydrogel materials using geometries from complex mathematics to offer comfortable wear and excellent vision.
This patented technology allows for custom-made contact lenses for irregular corneas and keratoconus to fit patients’ exact needs.
Patients with irregular corneas can have considerably reduced vision that is not adequately addressed by standard contact lenses. These patients have traditionally been limited to hard or rigid gas permeable lenses, which sometimes resulted in reduced wear time. KeraSoft lenses can increase wearing time for some of these patients.
By utilising Bausch + Lomb distribution channels throughout the world, Bausch + Lomb and UltraVision plan to significantly increase the number of patients globally who are able to benefit from customised KeraSoft contact lenses.
The global roll-out of KeraSoft lenses will begin later this year and will be executed around the world in phases.
• PHOTOGRAPH SHOWS: J Keith Lomas, group CEO of UltraVision CLPL